Home NDC 66689-108-10 Lacosamide
Product NDC 66689-108
Requested package NDC 66689-108-10
11-digit product format 666890108
Labeler code 66689
Product ID 66689-108_8164ec13-4fbf-410d-8238-b73beb3034cd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lacosamide
Dosage form SOLUTION
Route ORAL
Labeler VistaPharm, Inc.
Application NDA022255
Marketing category NDA
Marketing start 2021-11-15
Marketing end 0000-00-00
Substance LACOSAMIDE
Active strength 100 mg/10mL
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA schedule CV
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022255-001 VIMPAT LACOSAMIDE 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022255-001 AA
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N022255-001 D-188 2026-04-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL RLD, RS 2010-04-20 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022255-001 VIMPAT 10MG/ML SOLUTION / ORAL AA RLD, RS 2010-04-20 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N022255-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N022255-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022255-001 RE38551 2022-03-17 U-2140 Drug substance, Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022255-001 RE38551 2022-03-17 U-1567 Drug substance, Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N022255-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 8869cabd3fbd…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 68 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 66689-108-10 66689010810 10 CUP, UNIT-DOSE in 1 CASE (66689-108-10) > 10 mL in 1 CUP, UNIT-DOSE (66689-108-01) 2021-11-15 0000-00-00 No No Current